ID   WAe009-A-50
AC   CVCL_A5EP
SY   H9SNTA1KO; CMUe010-A-50
DR   hPSCreg; WAe009-A-50
DR   Wikidata; Q107117425
RX   PubMed=33524674;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11167; SNTA1.
CC   Caution: There seems to be two H9SNTA1KO cell line established in China, this one and CVCL_C5TU.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192202; Long QT syndrome 12
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
RX   PubMed=33524674; DOI=10.1016/j.scr.2021.102196;
RA   Dong T., Zhang S.-Y., Chang Y., Bai R., Jiang Y.-X., Ma S.-H., Li Y.-N.,
RA   Jiang H.-F., Lu W.-J.;
RT   "The establishment of a homozygous SNTA1 knockout human embryonic stem
RT   cell line (WAe009-A-50) using the CRISPR/Cas9 system.";
RL   Stem Cell Res. 51:102196-102196(2021).
//